Citation

Cotrina Luque J, Guerrero Aznar MD, Alvarez Del Vayo Benito C, Jimenez Mesa E, Guzman Laura KP, Fernández Fernández L. An. Pediatr. 2013; 79(6): 360-366.

Vernacular Title

Lista modelo de medicamentos de alto riesgo.

Affiliation

Hospital Universitario Virgen del Rocío, Sevilla, España. Electronic address: jesus.cotrina.luque@gmail.com.

Copyright

(Copyright © 2013, Asociacion Espanola de Pediatria, Publisher Elsevier Publishing)

DOI

10.1016/j.anpedi.2013.04.026

PMID

23746740

Abstract

INTRODUCTION: "High-risk drugs" are those that have a very high "risk" of causing death or serious injury if an error occurs during its use. The Institute for Safe Medication Practices (ISMP) has prepared a high-risk drugs list applicable to the general population (with no differences between the pediatric and adult population). Thus, there is a lack of information for the pediatric population. The main objective of this work is to develop a high-risk drug list adapted to the neonatal or pediatric population as a reference model for the pediatric hospital health workforce. MATERIAL AND METHODS: We made a literature search in May 2012 to identify any published lists or references in relation to pediatric and/or neonatal high-risk drugs. RESULTS: A total of 15 studies were found, from which 9 were selected. A model list was developed mainly based on the ISMP one, adding strongly perceived pediatric risk drugs and removing those where the pediatric use was anecdotal. CONCLUSIONS: There is no published list that suits pediatric risk management. The list of pediatric and neonatal high-risk drugs presented here could be a "reference list of high-risk drugs " for pediatric hospitals. Using this list and training will help to prevent medication errors in each drug supply chain (prescribing, transcribing, dispensing and administration).

Language: es